+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Rare Disease Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • PDF Icon

    Report

  • 116 Pages
  • June 2024
  • Region: Global
  • Prof Research
  • ID: 5392207
Description Jump to:

Quick Summary:

In the dynamic and ever-evolving pharmaceutical landscape, the development of drugs for rare diseases has become an area of critical focus, bringing hope to those affected by conditions often overlooked in broader healthcare strategies. As these advancements continue, astute market intelligence becomes indispensable for stakeholders aiming to navigate the intricate rare disease drug market effectively. This comprehensive report is tailored to provide senior business executives with a strategic edge, enabling informed decision-making and sound investment strategies.

The granularity of our analysis extends beyond mere market size; it delves into the nuanced supply and demand rhythms of the rare disease drug sector across significant global regions. We offer a detailed examination of critical markets including North America, Asia & Pacific, Europe, and more—each with its own unique set of players, challenges, and opportunities. As competition intensifies, our report also highlights competitive intelligence with SWOT analyses of major and emerging players and meticulously tracks the commercial movements within different channels, from hospital to retail pharmacies.

Your strategic foresight will be sharpened, ensuring your business decisions are backed by thorough research and sector-specific trends and projections. This rare disease drug market report is your compass to guide you through the complexities of the market and towards a future of growth and innovation.

This report describes the global market size of Rare Disease Drug from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Rare Disease Drug as well as some smaller players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Applications Segment:

  • Oncology
  • Hematology
  • Immunology
  • Metabolism
  • Respiratory
  • Cardiovasculars

Companies Covered:

  • Johnson & Johnson
  • Bristol-Myers Squibb
  • Merck & Co
  • AbbVie
  • Roche
  • Amgen
  • Novartis
  • Vertex
  • AstraZenec
  • Pfizer
  • Bayer
  • Takeda Pharmaceutical
  • Merck KGaA
  • GSK
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Rare Disease Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Rare Disease Drug Market in North America (2019-2029)
8.1 Rare Disease Drug Market Size
8.2 Rare Disease Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Rare Disease Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Rare Disease Drug Market in South America (2019-2029)
9.1 Rare Disease Drug Market Size
9.2 Rare Disease Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Rare Disease Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Rare Disease Drug Market in Asia & Pacific (2019-2029)
10.1 Rare Disease Drug Market Size
10.2 Rare Disease Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Rare Disease Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Rare Disease Drug Market in Europe (2019-2029)
11.1 Rare Disease Drug Market Size
11.2 Rare Disease Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Rare Disease Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Rare Disease Drug Market in MEA (2019-2029)
12.1 Rare Disease Drug Market Size
12.2 Rare Disease Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Rare Disease Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Rare Disease Drug Market (2019-2024)
13.1 Rare Disease Drug Market Size
13.2 Rare Disease Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Rare Disease Drug Market Size by Type
Chapter 14 Global Rare Disease Drug Market Forecast (2024-2029)
14.1 Rare Disease Drug Market Size Forecast
14.2 Rare Disease Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Rare Disease Drug Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Johnson & Johnson
15.1.1 Company Profile
15.1.2 Main Business and Rare Disease Drug Information
15.1.3 SWOT Analysis of Johnson & Johnson
15.1.4 Johnson & Johnson Rare Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
15.2 Bristol-Myers Squibb
15.2.1 Company Profile
15.2.2 Main Business and Rare Disease Drug Information
15.2.3 SWOT Analysis of Bristol-Myers Squibb
15.2.4 Bristol-Myers Squibb Rare Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
15.3 Merck & Co
15.3.1 Company Profile
15.3.2 Main Business and Rare Disease Drug Information
15.3.3 SWOT Analysis of Merck & Co
15.3.4 Merck & Co Rare Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
15.4 AbbVie
15.4.1 Company Profile
15.4.2 Main Business and Rare Disease Drug Information
15.4.3 SWOT Analysis of AbbVie
15.4.4 AbbVie Rare Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
15.5 Roche
15.5.1 Company Profile
15.5.2 Main Business and Rare Disease Drug Information
15.5.3 SWOT Analysis of Roche
15.5.4 Roche Rare Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
15.6 Amgen
15.6.1 Company Profile
15.6.2 Main Business and Rare Disease Drug Information
15.6.3 SWOT Analysis of Amgen
15.6.4 Amgen Rare Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
15.7 Novartis
15.7.1 Company Profile
15.7.2 Main Business and Rare Disease Drug Information
15.7.3 SWOT Analysis of Novartis
15.7.4 Novartis Rare Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
15.8 Vertex
15.8.1 Company Profile
15.8.2 Main Business and Rare Disease Drug Information
15.8.3 SWOT Analysis of Vertex
15.8.4 Vertex Rare Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
15.9 AstraZenec
15.9.1 Company Profile
15.9.2 Main Business and Rare Disease Drug Information
15.9.3 SWOT Analysis of AstraZenec
15.9.4 AstraZenec Rare Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
15.10 Pfizer
15.10.1 Company Profile
15.10.2 Main Business and Rare Disease Drug Information
15.10.3 SWOT Analysis of Pfizer
15.10.4 Pfizer Rare Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
15.11 Bayer
15.11.1 Company Profile
15.11.2 Main Business and Rare Disease Drug Information
15.11.3 SWOT Analysis of Bayer
15.11.4 Bayer Rare Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
15.12 Takeda Pharmaceutical
15.12.1 Company Profile
15.12.2 Main Business and Rare Disease Drug Information
15.12.3 SWOT Analysis of Takeda Pharmaceutical
15.12.4 Takeda Pharmaceutical Rare Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
15.13 Merck KGaA
15.13.1 Company Profile
15.13.2 Main Business and Rare Disease Drug Information
15.13.3 SWOT Analysis of Merck KGaA
15.13.4 Merck KGaA Rare Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
15.14 GSK
15.14.1 Company Profile
15.14.2 Main Business and Rare Disease Drug Information
15.14.3 SWOT Analysis of GSK
15.14.4 GSK Rare Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
15.15 Jazz
15.15.1 Company Profile
15.15.2 Main Business and Rare Disease Drug Information
15.15.3 SWOT Analysis of Jazz
15.15.4 Jazz Rare Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
15.16 Sanofi
15.16.1 Company Profile
15.16.2 Main Business and Rare Disease Drug Information
15.16.3 SWOT Analysis of Sanofi
15.16.4 Sanofi Rare Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
15.17 Novo Nordisk
15.17.1 Company Profile
15.17.2 Main Business and Rare Disease Drug Information
15.17.3 SWOT Analysis of Novo Nordisk
15.17.4 Novo Nordisk Rare Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
15.18 Eisai
15.18.1 Company Profile
15.18.2 Main Business and Rare Disease Drug Information
15.18.3 SWOT Analysis of Eisai
15.18.4 Eisai Rare Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
15.19 BioMarin
15.19.1 Company Profile
15.19.2 Main Business and Rare Disease Drug Information
15.19.3 SWOT Analysis of BioMarin
15.19.4 BioMarin Rare Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
15.20 Eli Lilly
15.20.1 Company Profile
15.20.2 Main Business and Rare Disease Drug Information
15.20.3 SWOT Analysis of Eli Lilly
15.20.4 Eli Lilly Rare Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
15.21 Biogen
15.21.1 Company Profile
15.21.2 Main Business and Rare Disease Drug Information
15.21.3 SWOT Analysis of Biogen
15.21.4 Biogen Rare Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Rare Disease Drug Report
Table Data Sources of Rare Disease Drug Report
Table Major Assumptions of Rare Disease Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Rare Disease Drug Picture
Table Rare Disease Drug Classification
Table Rare Disease Drug Applications
Table Drivers of Rare Disease Drug Market
Table Restraints of Rare Disease Drug Market
Table Opportunities of Rare Disease Drug Market
Table Threats of Rare Disease Drug Market
Table COVID-19 Impact For Rare Disease Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of Rare Disease Drug
Table Cost Structure Analysis of Rare Disease Drug
Table Key End Users
Table Latest News of Rare Disease Drug Market
Table Merger and Acquisition
Table Planned/Future Project of Rare Disease Drug Market
Table Policy of Rare Disease Drug Market
Table 2019-2029 North America Rare Disease Drug Market Size
Figure 2019-2029 North America Rare Disease Drug Market Size and CAGR
Table 2019-2029 North America Rare Disease Drug Market Size by Application
Table 2019-2024 North America Rare Disease Drug Key Players Revenue
Table 2019-2024 North America Rare Disease Drug Key Players Market Share
Table 2019-2029 North America Rare Disease Drug Market Size by Type
Table 2019-2029 United States Rare Disease Drug Market Size
Table 2019-2029 Canada Rare Disease Drug Market Size
Table 2019-2029 Mexico Rare Disease Drug Market Size
Table 2019-2029 South America Rare Disease Drug Market Size
Figure 2019-2029 South America Rare Disease Drug Market Size and CAGR
Table 2019-2029 South America Rare Disease Drug Market Size by Application
Table 2019-2024 South America Rare Disease Drug Key Players Revenue
Table 2019-2024 South America Rare Disease Drug Key Players Market Share
Table 2019-2029 South America Rare Disease Drug Market Size by Type
Table 2019-2029 Brazil Rare Disease Drug Market Size
Table 2019-2029 Argentina Rare Disease Drug Market Size
Table 2019-2029 Chile Rare Disease Drug Market Size
Table 2019-2029 Peru Rare Disease Drug Market Size
Table 2019-2029 Asia & Pacific Rare Disease Drug Market Size
Figure 2019-2029 Asia & Pacific Rare Disease Drug Market Size and CAGR
Table 2019-2029 Asia & Pacific Rare Disease Drug Market Size by Application
Table 2019-2024 Asia & Pacific Rare Disease Drug Key Players Revenue
Table 2019-2024 Asia & Pacific Rare Disease Drug Key Players Market Share
Table 2019-2029 Asia & Pacific Rare Disease Drug Market Size by Type
Table 2019-2029 China Rare Disease Drug Market Size
Table 2019-2029 India Rare Disease Drug Market Size
Table 2019-2029 Japan Rare Disease Drug Market Size
Table 2019-2029 South Korea Rare Disease Drug Market Size
Table 2019-2029 Southeast Asia Rare Disease Drug Market Size
Table 2019-2029 Australia Rare Disease Drug Market Size
Table 2019-2029 Europe Rare Disease Drug Market Size
Figure 2019-2029 Europe Rare Disease Drug Market Size and CAGR
Table 2019-2029 Europe Rare Disease Drug Market Size by Application
Table 2019-2024 Europe Rare Disease Drug Key Players Revenue
Table 2019-2024 Europe Rare Disease Drug Key Players Market Share
Table 2019-2029 Europe Rare Disease Drug Market Size by Type
Table 2019-2029 Germany Rare Disease Drug Market Size
Table 2019-2029 France Rare Disease Drug Market Size
Table 2019-2029 United Kingdom Rare Disease Drug Market Size
Table 2019-2029 Italy Rare Disease Drug Market Size
Table 2019-2029 Spain Rare Disease Drug Market Size
Table 2019-2029 Belgium Rare Disease Drug Market Size
Table 2019-2029 Netherlands Rare Disease Drug Market Size
Table 2019-2029 Austria Rare Disease Drug Market Size
Table 2019-2029 Poland Rare Disease Drug Market Size
Table 2019-2029 Russia Rare Disease Drug Market Size
Table 2019-2029 MEA Rare Disease Drug Market Size
Figure 2019-2029 MEA Rare Disease Drug Market Size and CAGR
Table 2019-2029 MEA Rare Disease Drug Market Size by Application
Table 2019-2024 MEA Rare Disease Drug Key Players Revenue
Table 2019-2024 MEA Rare Disease Drug Key Players Market Share
Table 2019-2029 MEA Rare Disease Drug Market Size by Type
Table 2019-2029 Egypt Rare Disease Drug Market Size
Table 2019-2029 Israel Rare Disease Drug Market Size
Table 2019-2029 South Africa Rare Disease Drug Market Size
Table 2019-2029 Gulf Cooperation Council Countries Rare Disease Drug Market Size
Table 2019-2029 Turkey Rare Disease Drug Market Size
Table 2019-2024 Global Rare Disease Drug Market Size by Region
Table 2019-2024 Global Rare Disease Drug Market Size Share by Region
Table 2019-2024 Global Rare Disease Drug Market Size by Application
Table 2019-2024 Global Rare Disease Drug Market Share by Application
Table 2019-2024 Global Rare Disease Drug Key Vendors Revenue
Figure 2019-2024 Global Rare Disease Drug Market Size and Growth Rate
Table 2019-2024 Global Rare Disease Drug Key Vendors Market Share
Table 2019-2024 Global Rare Disease Drug Market Size by Type
Table 2019-2024 Global Rare Disease Drug Market Share by Type
Table 2024-2029 Global Rare Disease Drug Market Size by Region
Table 2024-2029 Global Rare Disease Drug Market Size Share by Region
Table 2024-2029 Global Rare Disease Drug Market Size by Application
Table 2024-2029 Global Rare Disease Drug Market Share by Application
Table 2024-2029 Global Rare Disease Drug Key Vendors Revenue
Figure 2024-2029 Global Rare Disease Drug Market Size and Growth Rate
Table 2024-2029 Global Rare Disease Drug Key Vendors Market Share
Table 2024-2029 Global Rare Disease Drug Market Size by Type
Table 2024-2029 Rare Disease Drug Global Market Share by Type

Companies Mentioned

  • Johnson & Johnson
  • Bristol-Myers Squibb
  • Merck & Co
  • AbbVie
  • Roche
  • Amgen
  • Novartis
  • Vertex
  • AstraZenec
  • Pfizer
  • Bayer
  • Takeda Pharmaceutical
  • Merck KGaA
  • GSK
  • Jazz
  • Sanofi
  • Novo Nordisk
  • Eisai
  • BioMarin
  • Eli Lilly
  • Biogen

Methodology

Loading
LOADING...

Related Topics

Related Reports

Orphan Drug Growth Opportunities - Product Image

Orphan Drug Growth Opportunities

  • Report
  • 78 Pages
  • Global
From
Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World - Product Image

Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World

  • Report
  • 63 Pages
  • Global
The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Canada Edition - The Views of 100 Canadian Patient Groups - Product Image

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Canada Edition - The Views of 100 Canadian Patient Groups

  • Report
  • 50 Pages
  • Canada
Specialty Pharmaceuticals Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Specialty Pharmaceuticals Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 190 Pages
  • Global
From
Top 5 Growth Opportunities for the Pharmaceutical Industry, 2024 - Product Image

Top 5 Growth Opportunities for the Pharmaceutical Industry, 2024

  • Report
  • 12 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.